1. Home
  2. MTSR vs MLCO Comparison

MTSR vs MLCO Comparison

Compare MTSR & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTSR
  • MLCO
  • Stock Information
  • Founded
  • MTSR 2022
  • MLCO 2004
  • Country
  • MTSR United States
  • MLCO Hong Kong
  • Employees
  • MTSR N/A
  • MLCO N/A
  • Industry
  • MTSR
  • MLCO Hotels/Resorts
  • Sector
  • MTSR
  • MLCO Consumer Discretionary
  • Exchange
  • MTSR NYSE
  • MLCO Nasdaq
  • Market Cap
  • MTSR 3.0B
  • MLCO 2.5B
  • IPO Year
  • MTSR 2025
  • MLCO 2006
  • Fundamental
  • Price
  • MTSR $29.60
  • MLCO $6.41
  • Analyst Decision
  • MTSR Strong Buy
  • MLCO Hold
  • Analyst Count
  • MTSR 6
  • MLCO 5
  • Target Price
  • MTSR $55.25
  • MLCO $7.10
  • AVG Volume (30 Days)
  • MTSR 1.0M
  • MLCO 2.1M
  • Earning Date
  • MTSR 05-12-2025
  • MLCO 08-12-2025
  • Dividend Yield
  • MTSR N/A
  • MLCO N/A
  • EPS Growth
  • MTSR N/A
  • MLCO N/A
  • EPS
  • MTSR N/A
  • MLCO 0.14
  • Revenue
  • MTSR N/A
  • MLCO $4,758,114,000.00
  • Revenue This Year
  • MTSR N/A
  • MLCO $9.46
  • Revenue Next Year
  • MTSR N/A
  • MLCO $3.92
  • P/E Ratio
  • MTSR N/A
  • MLCO $44.71
  • Revenue Growth
  • MTSR N/A
  • MLCO 14.07
  • 52 Week Low
  • MTSR $12.30
  • MLCO $4.55
  • 52 Week High
  • MTSR $37.99
  • MLCO $8.90
  • Technical
  • Relative Strength Index (RSI)
  • MTSR N/A
  • MLCO 56.61
  • Support Level
  • MTSR N/A
  • MLCO $6.00
  • Resistance Level
  • MTSR N/A
  • MLCO $6.48
  • Average True Range (ATR)
  • MTSR 0.00
  • MLCO 0.21
  • MACD
  • MTSR 0.00
  • MLCO -0.01
  • Stochastic Oscillator
  • MTSR 0.00
  • MLCO 75.68

About MTSR METSERA INC

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.

About MLCO Melco Resorts & Entertainment Limited

Melco Resorts and Entertainment Ltd is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 81% from Macao with the rest largely from the Philippines as of 2024.

Share on Social Networks: